Wordt geladen...
Should AFP (or any biomarkers) be used for HCC surveillance?
A) PURPOSE OF REVIEW: To address the controversy around the use of biomarkers for hepatocellular carcinoma (HCC) surveillance in individuals with cirrhosis or chronic hepatitis B who are at risk for development of liver cancer. B) RECENT FINDINGS: Recent studies suggest that surveillance for hepatoc...
Bewaard in:
Gepubliceerd in: | Curr Hepatol Rep |
---|---|
Hoofdauteurs: | , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659201/ https://ncbi.nlm.nih.gov/pubmed/29085770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-017-0349-7 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|